Spire by St Brides

RBS Not Yet Strong, Simple or Fair But It Has Plans

Royal Bank Scotland Grp RBS is on target to meet all of its financial targets for 2017. Third quarter adjusted income rose by 5.6% and for the nine months to date by 7.5%. Basic earnings per share rose from a loss of 3.9p last year to a positive 5.7% this year whilst over 9 months […]

Lloyds – The UK Economy Is Resilient

Lloyds Banking Group LLOY produced a strong financial performance in the nine months to the 30th September with profits improved on both an underlying and on a statutory basis. Underlying profit rose by 8% and total income by 6%. The improvement continued into the third quarter which saw income rising by 8%. Statutory profit before […]

Quoted Micro 23 October 2017

NEX EXCHANGE Supported housing developer Walls and Futures REIT (WAFR) has improved its net asset value by 4.4% to 94p a share in the six months to September 2017. Interim figures should be published within a fortnight. African Potash Ltd (AFPO) has decided not to acquire investment company Onshore Energy Ltd and concentrate on its […]

Intercontinental Hotels – Strong On Jargon, Rev Par And Growing Rooms

Intercontinental Hotel Grp. IHG delivers a jargon laden third quarter update indicating that it is very pleased with itself. Net rooms grew at 4.1%, the strongest since 2010 and it is accelerating brand growth around the world. Rev Par 2.3% in the quarter and  2.2% for the year to date.Europe was particularly strong with rises […]

Unilever Ice Cream Sales Melt In Europe

Unilever plc ULVR Reports that emerging markets drove third quarter sales growth with underlying sales up by 2.6% and, over nine months, by 2.8%. Total third quarter turnover however was down by 1.6% after a 5.1 % currency impact. Developed markets were a problem and remained challenging, with turnover, led by of all things, ice […]

Spectra Systems – To Significantly Exceed Expectations

Spectra Systems SPSY has been notified by its authentication technology licensee that royalties in 2017 will reach a record level to the extent that profits for the year to 31st December will significantly exceed market expectations. For 2018 it is expected that royalties will continue to be higher than average. Bioventix BVXP is increasing its […]

Quoted Micro 16 October 2017

NEX EXCHANGE This month marks the 22nd anniversary of the launch of NEX Exchange, although it was then originally called Ofex. A number of companies have gone on to bigger things, including Genus, which is in the FTSE250 index and accesso Technology, which is one of the top 50 companies on AIM. Further information can […]

Buy Immupharma (IMM) says VectorVest. This pharma stock still offers further upside for the adventurous investor.

AIM listed ImmuPharma (IMM.L) is a drug discovery and development company. The London-based Company is focused on the development of drugs, primarily based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. IMM has approximately five drug candidates in development, over two platform technologies and approximately 70 patents. Lupuzor is the Company’s […]

Quoted Micro 9 October 2017

NEX EXCHANGE National Milk Records (NMRP) has changed its year end to June and its latest figures are for the 15 months to June 2017. This is a period when the dairy information and data services provider sorted out its pension deficit problem and this removed significant, and volatile, liabilities from the balance sheet. The […]